Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00138931 · ClinicalTrials.gov registry record
Genetics of Cardiovascular and Neuromuscular Disease
A clinical trial of Cardiomyopathy and Arrhythmia, sponsored by University of Chicago.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT00138931: Recruiting study of Cardiomyopathy and Arrhythmia, sponsored by University of Chicago.
NCT00138931 is a study of Cardiomyopathy and Arrhythmia that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 2,000 participants, above the 477-participant average among 25 other Cardiomyopathy trials with a reported enrollment target (319% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00138931, a study of Cardiomyopathy and Arrhythmia, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
We are studying the genetics of human cardiovascular and neuromuscular disease. There are many different genetic regions that have been associated with the development of cardiomyopathy. An equal number of genetic regions have been associated with muscular dystrophy and there is overlap because some of the identical genes, when mutated, produce both cardiomyopathy and muscular dystrophy. We are working to identify genes and gene mutations associated with cardiomyopathy, arrhythmias and muscular dystrophy. We propose to screen these samples for mutations in genes known to be involved in these disorders.
Conditions Studied
Interventions
- PROCEDURE Blood draw (genetic testing)
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 1996-09 |
| Est. Completion | 2030-01 |
What NCT00138931 shows while recruiting
NCT00138931 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 477-participant average among 25 other Cardiomyopathy trials with a reported enrollment target (319% higher).
The record links to 3 conditions, with Cardiomyopathy appearing as the primary indexed condition, and to 1 intervention - of which Blood draw (genetic testing) is the first listed.
NCT00138931 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00138931 about?
NCT00138931 is a clinical study titled "Genetics of Cardiovascular and Neuromuscular Disease". We are studying the genetics of human cardiovascular and neuromuscular disease. There are many different genetic regions that have been associated with the development of cardiomyopathy. An equal number of genetic regions have been associated with muscular dystrophy and there is overlap because some...
What is the current status of trial NCT00138931?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 1996-09. Estimated completion is 2030-01.
What conditions does trial NCT00138931 study?
This clinical trial studies the following conditions: Cardiomyopathy, Arrhythmia, Muscular Dystrophy.
What interventions are being tested in trial NCT00138931?
The interventions under investigation include: Blood draw (genetic testing) (PROCEDURE).
Who is sponsoring clinical trial NCT00138931?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00138931 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiomyopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00138931's enrollment target sits among peer trials
2,000 2nd of 25 higher than 23 of 25 other Cardiomyopathy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiomyopathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
RECRUITING
-
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
RECRUITING · Phase 4
-
Molecular Imaging of Primary Amyloid Cardiomyopathy
RECRUITING · NA
-
Impella Reverse Remodeling in End-Stage Heart Failure
RECRUITING
-
Clinical Course Of Disease In Participants With FA-CM
RECRUITING
-
Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
- NCT00349830 · 2,000 participants
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia